引用次数
引用: 74,267
H-指数: 110
I10-指数 : 335
出版物: 704
Neuropsychiatric Syndromes in Neurodegenerative Disease: Frequency and Signficance.
JL Cummings , C Diaz , M Levy , G Binetti
Seminars in Clinical Neuropsychiatry 1 ( 4) 241 -247
40
1996
Agitation and Apathy in Hyper- and Hypokinetic Movement Disorders
Irene Litvan , Jaime Kulisevsky
Humana Press, Totowa, NJ 339 -349
2
2003
Neuropsychiatric aspects of corticobasal degeneration.
Irene Litvan , Jeffrey L. Cummings
Advances in Neurology 82 147 -152
27
2000
Longitudinal Voxel-Based Analysis of Brain Atrophy over 6 and 12 Months in CBD and PSP from Two Multicenter Studies (S15.007)
Shubir Dutt , Richard Binney , Hilary Heuer , Priyanka Bhatt
Neurology 84
1
2015
Preliminary Results of the NINDS/NIBIB Consensus Meeting to Evaluate Pathological Criteria for the Diagnosis of CTE (P2.178)
Nigel Cairns , Rebecca Folkerth , Irene Litvan , Thomas Montine
Neurology 84
1
2015
Progressive Supranuclear Palsy and Corticobasal Degeneration
Irene Litvan , Keith A. Josephs , Dennis W. Dickson , David G. Coughlin
Advances in Experimental Medicine and Biology 1281 151 -176
12
2011
Examining the motor phenotype of patients with both essential tremor and Parkinson's disease.
Irene Litvan , Elan D. Louis , Anne Constantino , Eliza Gibadullina
Tremor and other hyperkinetic movements (New York, N.Y.) 2 02
11
2012
The Role of Life Stressors in the Etiopathogenesis of Progressive Supranuclear Palsy (P4.309)
Irene Litvan , Guerry Peavy , Kristen Kelley , Steven Edland
Neurology 86
2016
Validation of the MDS Clinical Diagnostic Criteria for Parkinson’s Disease (S3.001)
Elizabeth Slow , Klaus Seppi , Glenda Halliday , Werner Poewe
Neurology 90
2018
The Advancing Research and Treatment in Frontotemporal Lobar Degeneration (ARTFL) North American Rare Disease Clinical Research Consortium: Progress and Participant Characterization (S2.008)
Adam Boxer , Howard Rosen , Bradley Boeve , Hilary W Heuer
Neurology 90
2018
Multiple Ascending Dose Study of the Tau-Directed Monoclonal Antibody BIIB092 in Patients with Progressive Supranuclear Palsy (S27.004)
Michael Ahlijanian , Lawrence I. Golbe , Irene Litvan , Yvette Bordelon
Neurology 90
3
2018
Efficacy and Safety of BIIB092 in Patients with Progressive Supranuclear Palsy: PASSPORT Phase 2 Study Design (P6.073)
Lawrence I. Golbe , Irene Litvan , Clifford Bechtold , Irfan Qureshi
Neurology 90
4
2018
Sex differences for phenotype in pathologically defined dementia with Lewy bodies
Irene Litvan , Sarah J Banks , Ece Bayram , David G Coughlin
Journal of Neurology, Neurosurgery, and Psychiatry
2021
The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy
Kevin F Bieniek , Nigel J Cairns , John F Crary , Dennis W Dickson
Journal of Neuropathology and Experimental Neurology 80 ( 3) 210 -219
81
2021
Medication Management Performance in Parkinson's Disease: Examination of Process Errors.
Irene Litvan , J Vincent Filoteo , J Vincent Filoteo , Maureen Schmitter-Edgecombe
Archives of Clinical Neuropsychology
1
2021
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial.
Günter U Höglinger , Irene Litvan , Nuno Mendonca , Deli Wang
Lancet Neurology 20 ( 3) 182 -192
63
2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism
Alberto J. Espay , Irene Litvan , Kenneth W. Lyles , David G. Standaert
npj Parkinson's disease 7 ( 1) 16 -16
7
2021
Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia.
Irene Litvan , Tatiana M Foroud , Douglas R Galasko , Bradley F Boeve
Cortex 139 99 -115
2021
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials
Irene Litvan , Amber D. Van Laar , Alberto Romagnolo , Carlo Alberto Artusi
Frontiers in Neurology 12 648532 -648532
2021
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.
Sandro Sorbi , Irene Litvan , John C. van Swieten , Yvette Bordelon
Neurology 96 ( 18)
2021